Vivo Bio Tech Balance Sheet Annual

BSE: 511509 | NSE: - | ISIN: INE380K01017 | Sector: Biotechnology & Drugs

40.76 +2.02 (5.21%)Updated : 26 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	1.39	1.37	1.71	1.17
Cashand Short Term Investments	1.39	1.37	1.71	1.17
Accounts Receivable- Trade Net	11.80	12.38	12.02	7.29
Total Receivables Net	36.01	19.22	13.62	12.05
Total Inventory	8.77	7.97	9.81	13.28
Other Current Assets Total	1.06	3.23	0.89	0.59
Total Current Assets	47.23	31.79	26.03	27.09
Property/ Plant/ Equipment Total- Net	81.46	79.96	82.41	41.04
Intangibles Net	8.12	10.81	13.62	11.34
Other Long Term Assets Total	0.32	0.47	0.42	0.06
Total Assets	137.13	123.03	122.49	79.52
Accounts Payable	1.06	0.94	2.32	1.39
Current Portof LT Debt/ Capital Leases	31.28	7.72	17.36	4.38
Other Currentliabilities Total	5.58	4.72	4.69	4.14
Total Current Liabilities	37.91	24.97	24.36	21.84
Long Term Debt	41.79	42.56	50.08	14.23
Total Long Term Debt	41.79	43.09	50.08	14.65
Total Debt	73.06	62.40	67.44	30.96
Deferred Income Tax	2.34	2.48	1.54	0.03
Other Liabilities Total	0.69	0.61	0.55	0.48
Total Liabilities	82.73	71.16	76.54	37.00
Common Stock Total	14.90	14.90	14.26	13.42
Retained Earnings( Accumulated Deficit)	39.50	36.97	31.68	29.11
Total Equity	54.40	51.87	45.95	42.53
Total Liabilities Shareholders' Equity	137.13	123.03	122.49	79.52
Total Common Shares Outstanding	1.49	1.49	1.43	1.34
Tangible Book Valueper Share Common Eq	31.05	27.56	22.66	23.24
Notes Payable/ Short Term Debt	-	11.59	0.00	11.92
Capital Lease Obligations	-	0.53	-	0.42
Other Equity Total	-	-	0.00	-